Best Contract Sales Organizations (CSOs) in Healthcare 2026: An Honest Comparison
Marcus Webb
You're reading this because you have territories that need reps, and your internal team can't fill them fast enough. That's the reason anyone looks at CSOs.
So I'm going to skip the preamble and give you what you need: who the major players are, what they actually charge, where they deliver, and where they don't. Then I'll cover the alternative that's been quietly taking market share from traditional CSOs for the past three years.
What a CSO Actually Costs
Before we talk about specific companies, you need to understand the economics. Most CSOs won't publish their pricing, so let me give you a framework based on what I see in actual contracts.
A CSO hires a rep as a W2 employee. That rep might earn $87K base plus $25K in benefits, $9K in payroll taxes, and $12K in car and expenses. The CSO's actual cost per rep is roughly $133K.
The CSO charges you somewhere between $185K and $240K per rep annually, depending on therapeutic area, geography, and contract size. That $52K-$107K spread is recruiting, training, management overhead, and profit margin.
For a 10-rep deployment, you're paying $1.85M-$2.4M annually. The CSO's gross margin on that contract is somewhere around $520K-$1.07M.
That margin isn't evil. It pays for real services. But you should know what you're buying before you sign, because depending on your situation, you might be overpaying for services you don't need.
The Major Players
IQVIA
IQVIA is the biggest. They came out of the Quintiles-IMS merger, and they have more data, more infrastructure, and more deployed reps than anyone else in the space.
Where IQVIA wins: scale deployments. If you need 40 reps across 12 states in 90 days, IQVIA can do it. Their recruiting pipeline is deep enough to handle that volume. Their training programs are templated and efficient. Their management structure is built for large engagements.
Where IQVIA struggles: small, specialized needs. If you need 3 experienced oncology reps in the Northeast, IQVIA's machinery is overkill. You'll pay the same overhead percentage whether you're deploying 3 reps or 30. And because IQVIA is managing thousands of reps across hundreds of engagements, the individual attention to your specific program can feel thin.
Typical contract: 12-month minimum, 15-rep minimum in some cases, with 60-90 day termination notice. Pricing on the higher end of the range I mentioned above.
Syneos Health
Syneos Health combines contract sales with clinical development services. That integration is their pitch: you can get your Phase III trial and your launch team from the same company.
In practice, most clients use one side or the other. But for companies that genuinely need both, particularly mid-size pharma launching their first or second product, the integration can reduce coordination overhead.
Syneos has invested heavily in specialty pharma, and their rep quality in therapeutic areas like oncology and rare disease is generally strong. They're pickier about which reps they deploy, which means slower ramp-up but better performance once the team is in place.
Typical contract: 12-month minimum, pricing comparable to IQVIA, with some flexibility on smaller engagements.
Amplity Health
Amplity Health (formerly Publicis Health Solutions) differentiates by wrapping sales reps in a broader commercial package: medical science liaisons, nurse educators, digital engagement, and market access support.
If your product requires significant physician education alongside the sales effort, Amplity's integrated model can work. You're not just putting a rep in the territory; you're putting a mini commercial team in the territory. For complex biologics or specialty products where the clinical conversation is as important as the commercial one, that can be worth the premium.
The premium is real, though. Amplity's pricing reflects the breadth of services. If you only need sales coverage and nothing else, you're paying for capabilities you won't use.
Eversana
Eversana takes integration further than anyone else. They'll handle your distribution, patient services, market access, and field sales under one contract. It's essentially outsourced commercialization.
For pre-commercial pharma companies launching their first product, Eversana solves a real problem: you don't have any commercial infrastructure, and building it from scratch takes 18-24 months. Eversana can deploy a functioning commercial operation in a fraction of that time.
The tradeoff is dependency. When one vendor handles your distribution, your patient support program, and your sales force, you're deeply embedded. Switching providers or bringing functions in-house later is a major undertaking. Companies that grow successfully often outgrow the Eversana model and face a painful transition to internal operations.
What the Data Says About CSO Performance
There's a question that's hard to answer cleanly: do CSO reps perform as well as in-house reps?
The honest answer is it depends heavily on the therapeutic area, the CSO's recruiting standards, and how the engagement is managed. I've seen CSO teams that outperform in-house teams because the CSO recruited better talent for that specific situation. I've also seen CSO teams underperform because the reps were generalists assigned to a specialty role they weren't prepared for.
The structural issue is incentive alignment. A CSO is motivated to fill seats. They need utilization to generate revenue. That incentive can conflict with your need for the best possible rep in each territory. Good CSOs manage this tension through rigorous vetting. Mediocre CSOs fill seats and hope for the best.
One proxy metric I use: ask the CSO what percentage of deployed reps are replaced during the first six months of a contract. Industry average is somewhere around 15-22%. If a CSO tells you their number is under 10%, that's a good sign. If they won't share the number, draw your own conclusions.
The Model That's Taking Share
Over the past few years, a different approach has been gaining traction. Instead of contracting with a CSO that recruits, employs, and manages reps on your behalf, companies are working directly with pre-vetted independent sales professionals through talent marketplaces.
The economics are different. No CSO markup. No management overhead you're subsidizing. No 12-month minimums.
A contract rep through a marketplace typically costs 20-35% less than the same caliber rep through a traditional CSO, because you're not paying for the CSO's recruiting team, management layer, office infrastructure, and profit margin. You're paying the rep for their expertise and a platform fee for the matching service.
The reps in these networks tend to be experienced professionals who have deliberately chosen independent work. They're not between jobs. They're not hoping to get hired full-time somewhere. They're people with 8, 12, 15 years of experience who prefer the flexibility and variety of contract engagements. That self-selection tends to produce a higher floor of quality than a CSO that's recruiting from the general market.
The limitation is management. A traditional CSO provides a field management layer. Your regional manager at the CSO supervises the reps, handles performance issues, and reports to you. In the marketplace model, you're managing the reps more directly, or using your existing field management structure. If you already have regional managers and just need reps to manage, this isn't a problem. If you need someone else to handle everything, the CSO model still has its place.
MDliaison operates this way. We maintain a network of pre-vetted medical sales professionals across device, pharma, physician liaison, and software verticals. Companies tell us what they need, we match them with qualified professionals, and the engagement starts within weeks.
Making the Decision
Here's a quick rubric.
Choose a traditional CSO if you need 15+ reps deployed nationally, you want a fully managed solution with minimal internal oversight, and your budget accommodates the markup. IQVIA and Syneos are the strongest options at scale.
Choose a specialized CSO like Amplity if your product requires integrated medical education and sales support, particularly for complex specialty products.
Choose Eversana if you're a pre-commercial company that needs an entire commercial infrastructure built from scratch and you understand the dependency tradeoff.
Choose a marketplace model if you need fewer than 15 reps, you want experienced specialists rather than generalist reps, your needs are variable or shorter-term, you have existing field management, or the CSO markup doesn't make economic sense for your situation.
Do nothing if you're not sure what you need. Seriously. A bad outsourcing decision is expensive to unwind. Take the time to define the scope, the timeline, and the budget before you engage anyone.
The worst outcome isn't choosing the wrong model. It's leaving territories empty while you deliberate. Whatever you decide, decide quickly. Revenue doesn't wait.